BioGenes GmbH

BioGenes GmbH of Berlin, a developer of antibodies, has been chosen as a partner of cNEUPRO, a research project funded by the European Union. The project focuses on analyzing neurodegenerative diseases and discovering novel biomarkers, in hopes of providing early and differential diagnosis of Alzheimer’s disease. The company will provide laboratory facilities and personnel to develop monoclonal antibodies against specific dementia biomarkers in blood and cerebrospinal fluid.





LATEST NEWS

• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024